Bosh sahifaLILY34 • BVMF
add
Eli Lilly And Company BDR
Yopilish kursi
182,25 R$
Kunlik diapazon
179,71 R$ - 184,00 R$
Yillik diapazon
112,71 R$ - 208,36 R$
Bozor kapitalizatsiyasi
955,13 mlrd USD
Oʻrtacha hajm
20,08 ming
Narx/foyda
-
Dividend daromadliligi
-
Yangiliklarda
Investing.com
2 kun oldin
Eli Lilly stock price target raised to $1,200 by BMO on obesity drug outlook
0,41%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 17,60 mlrd | 53,87% |
Joriy xarajat | 6,09 mlrd | 29,12% |
Sof foyda | 5,58 mlrd | 475,34% |
Sof foyda marjasi | 31,72 | 274,06% |
Har bir ulushga tushum | 7,02 | 494,92% |
EBITDA | 8,97 mlrd | 78,81% |
Amaldagi soliq stavkasi | 22,81% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 9,91 mlrd | 181,76% |
Jami aktivlari | 114,94 mlrd | 52,02% |
Jami passivlari | 91,08 mlrd | 48,62% |
Umumiy kapital | 23,85 mlrd | — |
Tarqatilgan aksiyalar | 895,38 mln | — |
Narxi/balansdagi bahosi | 6,86 | — |
Aktivlardan daromad | 19,69% | — |
Kapitaldan daromad | 34,07% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 5,58 mlrd | 475,34% |
Operatsiyalardan naqd pul | 8,84 mlrd | 138,04% |
Sarmoyadan naqd pul | -2,98 mlrd | 25,52% |
Moliyadan naqd pul | 531,00 mln | 151,30% |
Naqd pulning sof oʻzgarishi | 6,42 mlrd | 4 312,65% |
Boʻsh pul | 2,22 mlrd | 256,60% |
Haqida
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 11th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so. Wikipedia
Tashkil etilgan
1876
Sayt
Xodimlar soni
47 000
